These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


211 related items for PubMed ID: 13618555

  • 1. The peripheral action of hexamethonium and of pentolinium.
    MANTEGAZZA P, TYLER C, ZAIMIS K.
    Br J Pharmacol Chemother; 1958 Dec; 13(4):480-4. PubMed ID: 13618555
    [Abstract] [Full Text] [Related]

  • 2. Pressor effects of adrenaline, noradrenaline and reflex vasoconstriction sensitised by low concentrations of ganglion blocking drugs.
    MAWJI S, LOCKETT MF.
    J Pharm Pharmacol; 1963 Jan; 15():45-55. PubMed ID: 13934052
    [No Abstract] [Full Text] [Related]

  • 3. Supersensitivity due to prolonged administration of ganglion-blocking compounds.
    EMMELIN N.
    Br J Pharmacol Chemother; 1959 Jun; 14(2):229-33. PubMed ID: 13662579
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of pentolinium on renal hemodynamics and water and electrolyte excretion: a comparison with hexamethonium.
    MOYER JH, HERSHBERGER RL.
    Am J Med Sci; 1956 Mar; 231(3):294-312. PubMed ID: 13292436
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mechanism of action of a new prostaglandin antihypertensive, viprostol [CL 115 347; (dl)-15-deoxy-16-hydroxy-16(alpha/beta)-vinyl-prostaglandin E2 methyl ester]: (II). Effects on the adrenergic nervous system.
    Chan PS, Cervoni P, Accomando RC, Quirk GJ, Ronsberg MA.
    J Hypertens; 1986 Dec; 4(6):749-57. PubMed ID: 2880911
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Potentiation of the pressor action of noradrenaline by hexamethonium, tetraethylammonium, and methantheline.
    BARTORELLI C, CARPI A, CAVALCA L.
    Br J Pharmacol Chemother; 1954 Dec; 9(4):476-80. PubMed ID: 13219272
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. THE GANGLION BLOCKING ACTION OF PROCAINAMIDE.
    PATON WD, THOMPSON JW.
    Br J Pharmacol Chemother; 1964 Feb; 22(1):143-53. PubMed ID: 14126044
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of the prevention of nicotine convulsions by hexamethonium and by adrenaline blocking agents.
    LAURENCE DR, STACEY RS.
    Br J Pharmacol Chemother; 1953 Mar; 8(1):62-5. PubMed ID: 13066696
    [No Abstract] [Full Text] [Related]

  • 15. Postganglionic sympathetic nerve innervating human fallopian tube.
    Nakanishi H, Wansbrough H, Wood C.
    Am J Physiol; 1967 Sep; 213(3):613-9. PubMed ID: 4382528
    [No Abstract] [Full Text] [Related]

  • 16. ON THE MECHANISM OF SENSIBILIZATION TO CATECHOLAMINES BY HEXONIUM (HEXAMETHONIUM).
    VITOLINA MA, MELZOBS MJ.
    Int J Neuropharmacol; 1964 Apr; 3():141-5. PubMed ID: 14334591
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cardiovascular effects of pentolinium bitartrate in dogs.
    SPOEREL WE, GOWDEY CW.
    Can J Biochem Physiol; 1956 Jul; 34(4):747-55. PubMed ID: 13343035
    [No Abstract] [Full Text] [Related]

  • 20. On the pharmacology of a benzoquinolizine derivative: Ro 4-1284.
    Vidal-Beretervide K, Trinidad H, Pritsch LE.
    Pharmacology; 1969 Jul; 2(2):113-23. PubMed ID: 5799558
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.